Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers

C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti

Hopital Pitie Salpetriere, Service Pharmacie-Pharmacocinetique, Paris, France.

The disposition of the enantiomers of zopiclone and its two chiral metabolites was investigated after oral administration of a single dose of 15 mg of a racemic mixture (twice the usual therapeutic regimen) in 12 adult Caucasian volunteers. Determination of concentrations of zopiclone enantiomers in plasma showed that zopiclone pharmacokinetics is stereoselective with AUC0-->infinity values of 691.3 and 209.5 ng.ml- 1.hr (p < 0.001), Cmax values of 87.3 and 44.0 ng.ml-1 (p < 0.001), oral CLtot/F values of 195.5 and 659.8 ml.min-1 (p < 0.001), Vd/F values of 98.6 and 192.8 liters (p < 0.01) and elimination half-life of 399.2 and 225.6 min (p < 0.01) for (+)-zopiclone and (-)-zopiclone, respectively. On the contrary, absorption half-life and Tmax values were not significantly different. In 48-hr urine, 3.6% of unchanged zopiclone was excreted, whereas 14.2% and 13.8% of both metabolites, N- desmethylzopiclone and N-oxidezopiclone, respectively, were found. Quantities of (+)-zopiclone excreted in urine were always higher compared with its antipode (-)-zopiclone for the 12 volunteers (p < 0.001). For the metabolites, quantities of both enantiomers were either equal or different and when different, it was always in favor of the (+)-enantiomer.

Volume 21, Issue 6, pp. 1125-1128, 11/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				R. K. Rippley, K. X. Yan, N. D. Matthews, H. E. Greenberg, G. A. Herman, and J. A. Wagner Human Pharmacokinetics and Interconversion of Enantiomers of MK-0767, a Dual PPAR{alpha}/{gamma} Agonist J. Clin. Pharmacol., March 1, 2007; 47(3): 323 - 333. [Abstract] [Full Text] [PDF]